Before joining Turenne Capital as Investment Director Healthcare in July 2022, Claire worked for 7 years in the Omnes Capital VC Healthcare team. She began her career in research at the Singapore Institute for Neurotechnology. Claire Poulard holds a master’s degree in Pharmaceutical Management and Biotechnology from ESCP Europe and a master in Bioengineering and Neuroscience Innovation from ESPCI (Ecole Supérieure de Physique et Chimie Industrielle).
![](https://antabio.com/wp-content/uploads/2022/10/Claire-Poulard-1-BD-scaled-e1666190725904-945x1024.jpg)